Gary Schubert v. Pfizer, Inc. , 459 F. App'x 568 ( 2012 )


Menu:
  •                      United States Court of Appeals
    FOR THE EIGHTH CIRCUIT
    ___________
    No. 11-1726
    ___________
    Gary Schubert,                            *
    *
    Plaintiff – Appellant,      *
    * Appeal from the United States
    v.                                 * District Court for the
    * Southern District of Iowa.
    Pfizer, Inc.; Paul Plofchan; Mike         *
    Lynch,                                    *
    * [UNPUBLISHED]
    Defendants – Appellees. *
    ___________
    Submitted: January 9, 2012
    Filed: February 1, 2012
    ___________
    Before MURPHY, BYE, and COLLOTON, Circuit Judges.
    ___________
    PER CURIAM.
    Gary Schubert, a former Pfizer, Inc., pharmaceutical sales representative,
    brought suit against Pfizer and his former district managers, Paul Plofchan and Mike
    Lynch (collectively, “Pfizer”), alleging age discrimination, harassment, and
    retaliation. The district court1 dismissed Schubert’s case as a sanction for repeated
    discovery violations. On appeal, Schubert contends the district court clearly erred in
    finding he wilfully violated court orders compelling discovery, and abused its
    1
    The Honorable Robert W. Pratt, United States District Judge for the Southern
    District of Iowa.
    discretion by dismissing his case with prejudice and adopting the magistrate judge’s2
    recommendation Schubert pay Pfizer $53,255.55 in fees and costs. We affirm.
    I
    Initial discovery disputes came to a head in February 2010, ten months after
    Schubert initially filed his complaint, when Pfizer filed a motion to compel.
    Specifically, Pfizer requested complete answers to a number of interrogatories and
    production of several documents. Pfizer requested Schubert’s tax returns and the
    identity of his medical providers, among other things, to assess Schubert’s claim of
    lost wages and medical and emotional distress damages. The magistrate judge
    granted Pfizer’s motion on March 12, 2010, and ordered compliance by April 5, 2010.
    Schubert failed to respond in a timely and meaningful way.
    On April 9, 2010, Pfizer filed its first Motion for the Sanction of Dismissal, in
    which it summarized Schubert’s failures to provide discovery and to comply with the
    March 12 order. On May 10, 2010, the magistrate judge held a telephonic hearing,
    and, although it did not grant Pfizer’s first motion to dismiss, it admonished Schubert
    for his numerous violations, and ordered him, among other things, to supplement his
    deficient answers to interrogatories relating to his financial activities, his efforts to
    mitigate damages, his medical providers, and to produce documents relating to his
    taxes, calendars, business entities, etc. The magistrate judge set a short deadline for
    compliance: May 14, 2010. Again, Schubert failed to fully comply.
    On May 20, 2010, the magistrate judge held another discovery hearing, lasting
    3 hours and consuming 120 pages of transcript. The magistrate judge ordered full
    production of Schubert’s tax returns and all relevant tax materials for 2005, 2009, and
    2
    The Honorable Celeste F. Bremer, United States Magistrate Judge for the
    Southern District of Iowa.
    -2-
    2010, the years for which Schubert had so far failed to produce any information. The
    magistrate judge gave Schubert until June 1, 2010, and emphasized the importance
    of her order: “I don’t want to get to June 1st and have people say, okay, ‘Now I just
    need another month,’ because we’ve horsed around on this for quite a while. So I
    will put June 1st, but I’m going to hold you to June 1st[.]” Hr’g Tr. at 30, May 20,
    2010. On June 4, 2010, the magistrate judge issued an order memorializing her
    rulings from the May 20, 2010, conference. In her order, the magistrate judge
    chastised Schubert and his counsel for their failures to comply with court orders and
    the Rules of Civil Procedure, sanctioned Schubert $3,000 for Pfizer’s costs and fees
    associated with his noncompliance, and ordered the parties to secure local counsel to
    participate in all significant discovery events and conferences. The magistrate judge
    then warned Schubert about the possibility of additional sanctions if his misconduct
    continued:
    It is apparent that Plaintiff’s counsel is not fluent in the Federal Rules
    of Civil Procedure, and that Plaintiff or his counsel have not completed
    production of documents in a prompt fashion. The ongoing delay and
    confusion in the completion of discovery has got to stop. Whether the
    delay has been caused by Plaintiff’s counsel, or Plaintiff himself, they
    are both advised that further unnecessary delay, or any obstruction of the
    discovery process, will result in the imposition of sanctions, which can
    include dismissal of the action. See Fed. R. Civ. P. 37(d).
    Order Denying Mot. to Dismiss at 9, June 4, 2010. Again, Schubert failed to fully
    comply.
    On July 7, 2010, the magistrate judge held another discovery hearing. During
    the hearing, the magistrate judge learned, among other things, Schubert (1) had yet
    to produce any documents relating to his financial activities for 2009 or 2010; (2) had
    yet to produce any organizational or financial documents relating to five businesses
    he was involved with—and that Schubert was not planning to meet with his tax
    -3-
    preparer regarding these companies until August 2010 due to Schubert’s own travel
    schedule; (3) Schubert had destroyed evidence; and (4) had not meaningfully
    supplemented or amended his interrogatory responses. Regarding Schubert’s failure
    to produce financial documents, the magistrate judge stated:
    So where is Mr. Schubert’s sense of urgency of being in compliance
    with my order to get that information by June 1st if he doesn’t have an
    appointment until August?
    ....
    I’m speechless. I mean, I cannot comprehend how Mr. Schubert is
    demonstrating good faith in complying with his obligations to provide
    discovery in this case. I mean, from the description of the material that
    was just provided today, best case it’s incomplete, and worst case it’s
    flat-out ignoring my order, and I tried to anticipate the argument of
    incompletion in my order. So I’m not hearing any good cause for the
    material to be incomplete.
    Hr’g Tr. at 16-17, July 7, 2010. Regarding Schubert’s discovery responses in general,
    the magistrate judge stated:
    [E]very step Plaintiff has taken has resulted in delay of discovery, and
    every morsel of information that’s been dribbled out has just been one
    piece of this jigsaw puzzle as opposed to giving Defendants the whole
    box with all the pieces in it.
    So I [am] having to parse through answers, plus supplemental material,
    plus something as basic as ‘What's your medical history,’ and still be
    flogging those questions six months into this year is inefficient and is
    incredibly expensive.
    ....
    I don’t know what else I can do in terms of discovery management. I tell
    you to produce something, I give you a deadline, and it never happens,
    so I get little parts of things, and it still doesn’t come out to be a full set
    -4-
    of discovery. The case has been on file for over a year, and we’re
    working Plaintiff’s damages issues, and it’s still—there’s nothing that’s
    gelled or come together in terms of that, and that’s assuming that there’s
    really nothing controversial about the damage claims, but just from this
    description of them it seems to me that it is controversial.
    
    Id. at 41-42.
    At the conclusion of the hearing, the magistrate judge invited Pfizer to
    re-file its April 2010 Motion for the Sanction of Dismissal. 
    Id. at 49-50.
    On July 16, 2010, Pfizer filed its Renewed Motion for the Sanction of
    Dismissal. On July 30, 2010, Schubert finally produced several hundred pages of
    documents to Pfizer, though it appears his production was still inadequate. The
    magistrate judge conducted another discovery hearing on August 3, 2010, and issued
    her Report and Recommendation on September 10, 2010: “In light of [Schubert’s]
    willful violations of Orders, previously sanctioned misconduct, his ongoing failure
    to engage fully in the discovery process, and lack of compliance with the Federal
    Rules of Civil Procedure,” the magistrate judge recommended Schubert’s lawsuit be
    dismissed with prejudice and Pfizer be awarded its reasonable costs and fees incurred
    as a result of Schubert’s conduct. Order and Report and Recommendation at 6-7,
    Sept. 10, 2010. Pursuant to Federal Rule of Civil Procedure 37(b)(2)(C) and 16(f)(2),
    and after considering Pfizer’s subsequent Statement of Costs and Fees and Schubert’s
    objections, the magistrate judge assessed those fees and costs to be $53,255.55 in a
    December 17, 2010, order. The order explained that “[a]ny appeal of [the costs and
    fees] will be considered with the Objections to the Report and Recommendation for
    Sanctions.” Order on Fees and Costs at 5, Dec. 17, 2010.
    Schubert filed objections to the magistrate judge’s Report and
    Recommendation on October 20, 2010, in which he requested a hearing in front of
    the district court. In those objections, Schubert did not make any reference to the
    magistrate judge’s recommendation he “pay Defendants the amount of their fees and
    costs involved in bringing the renewed Motion for Sanctions.” Order and Report and
    -5-
    Recommendation at 7, Sept. 10, 2010. Although Schubert’s reply in support of his
    objections did request “the opportunity to be heard” on the issue of fees and costs,
    Reply to Def.’s Resp. to Pl.’s Objections at 4, Dec. 3, 2010, Schubert did not state any
    specific objection. In addition, Schubert never filed an objection to the magistrate
    judge’s Dec. 17, 2010 Order on Fees and Costs in which the magistrate judge
    awarded Pfizer $53,255.55.
    The district court granted Schubert a hearing to discuss his objections, which
    it conducted on February 22, 2011. During the hearing, Schubert’s counsel did not
    raise the issue of costs and fees. The district court then issued an order on February
    28, 2011, finding “evidence of multiple violations of multiple orders, a pattern of
    conduct demonstrating willfulness, and prejudice to the Defendants.” Order Granting
    Mot. to Dismiss at 9, Feb. 28, 2011. Furthermore, the district court stated it was “not
    convinced that a less severe sanction could remedy the effect of Schubert’s
    transgression, or that, if the court denies Defendants’ motion, Schubert’s litigation
    conduct is likely to significantly improve.” 
    Id. (internal quotation
    marks and citation
    omitted).     The district court adopted the magistrate judge’s Report and
    Recommendation in its entirety, and dismissed Schubert’s case with prejudice. 
    Id. II On
    appeal, Schubert argues the district court abused its discretion by granting
    Pfizer’s Motion for the Sanction of Dismissal, and awarding Pfizer reasonable fees
    and costs associated with Schubert’s discovery violations.
    A. Dismissal With Prejudice
    Under Federal Rule of Civil Procedure 37(b)(2)(A), the district court may
    impose sanctions for discovery violations, including dismissal of the action in whole
    or in part. Because dismissal is an extreme result, we have allowed dismissal to “be
    -6-
    considered as a sanction only if there is: (1) an order compelling discovery; (2) a
    willful violation of that order; and (3) prejudice to the other party.” Keefer v.
    Provident Life and Acc. Ins. Co., 
    238 F.3d 937
    , 940 (8th Cir. 2000) (citing Schoffstall
    v. Henderson, 
    223 F.3d 818
    , 823 (8th Cir. 2000)). We review a district court’s
    imposition of such sanctions for abuse of discretion, 
    id., and “more
    closely scrutinize
    dismissal imposed as a discovery sanction because the opportunity to be heard is a
    litigant’s most precious right and should sparingly be denied.” 
    Id. at 940-41
    (internal
    quotation marks and citation omitted). We will review any factual findings made by
    the district court, including its “determination that appellant wilfully disregarded
    court orders[,]” for clear error. Rodgers v. Curators of Univ. of Mo., 
    135 F.3d 1216
    ,
    1219 (8th Cir. 1998); see also Avionic Co. v. Gen. Dynamics Corp., 
    957 F.2d 555
    ,
    558 (8th Cir. 1992) (reviewing the district court’s finding the party acted with willful
    disobedience for clear error). “[A] finding is clearly erroneous only when, even
    though there is evidence in the record to support it, the reviewing court is left with
    a definite and firm conviction that a mistake has been committed.” 
    Rodgers, 135 F.3d at 1220
    (internal quotation marks and citation omitted).
    After reviewing the record as a whole, we conclude the district court did not
    clearly err in finding Schubert’s violations of court orders willful; particularly,
    Schubert’s failure to produce all relevant tax returns and his destruction of evidence.
    See 
    id. (holding the
    district court did not err in concluding appellant willfully failed
    to produce financial documents); 
    Keefer, 238 F.3d at 941
    (refusing to second-guess
    the district court’s credibility determination the appellant had willfully destroyed
    calendar entries in violation of basic discovery obligations).
    Furthermore, the record supports the district court’s conclusion Schubert’s
    actions prejudiced Pfizer by preventing it from accurately assessing Schubert’s
    claims. See 
    Avionic, 957 F.2d at 559
    (“In the context of [Fed. R. Civ. P.] 37(b)(2)
    motions ‘prejudice’ exists if the failure to make discovery impairs the opponent’s
    ability to determine the factual merits of the party’s claim.”); see also Schoffstall, 223
    -7-
    F.3d at 824 (concluding prejudice existed where plaintiff’s misconduct forced
    defendants to spend significant amount of time “hounding” plaintiff for discovery
    instead of defending their case and preparing for trial).
    Having found no clear error in the district court’s factual findings, we next turn
    to whether the court abused its discretion in dismissing Schubert’s case with
    prejudice. Here, the district court not only found Schubert to have willfully violated
    court orders, but also noted its concern over the “combined impact of Schubert’s
    violations” and the “clear pattern of discovery malfeasance demonstrated by Schubert
    in this case.” Order Granting Mot. to Dismiss at 6, Feb. 28, 2011. In addition, the
    court properly distinguished this case from Sentis Grp., Inc., Coral Grp. Inc. v. Shell
    Oil Co., 
    559 F.3d 888
    (8th Cir. 2009), which Schubert again attempts to analogize to
    on appeal. In Sentis, we reversed the district court’s sanction of dismissal with
    prejudice, concluding such an order was an abuse of discretion when the evidence
    only clearly supported one minor, technical violation—a violation neither willful nor
    
    prejudicial. 559 F.3d at 903-04
    . The facts in Sentis are in sharp contrast with the
    pattern of violations present in this case. Furthermore, the district court already
    considered Schubert’s argument his violations were simply the result of
    inexperienced counsel doing the best he could in the face of a “well-oiled discovery
    machine” exploiting his every mistake. Appellant’s Reply Br. at 4; Pl.’s Obj. to
    Mag.’s Order and Rpt. and Recom. at 13, Oct. 20, 2010. In light of the district court’s
    findings discussed above, and upon our own careful review, we conclude the record
    supports the district court’s conclusion a less severe sanction would not remedy
    Schubert’s discovery violations. Therefore, the court’s decision to dismiss with
    prejudice was not an abuse of discretion. See Martin v. DaimlerChrysler Corp., 
    251 F.3d 691
    , 693-96 (8th Cir. 2001) (affirming dismissal where plaintiff committed
    several discovery violations, including failing to disclose numerous lawsuits to which
    she had been a party and failing to disclose the identity of certain health care
    providers); 
    Keefer, 238 F.3d at 941
    (affirming dismissal where plaintiff destroyed
    calendar entries, thereby prejudicing defendants). Cf. Arnold v. ADT Sec. Servs.,
    -8-
    Inc., 
    627 F.3d 716
    , 722-23 (8th Cir. 2010) (affirming dismissal under Rule 41(b)
    where district court “provided plaintiffs with numerous opportunities to comply with
    its discovery orders[, i]t attempted to address plaintiffs’ conduct through less severe
    sanctions[,] and warned plaintiffs of the possibility of dismissal.”); 
    Rodgers, 135 F.3d at 1218
    , 1221-22 (affirming dismissal under Rule 41(b) where plaintiff intentionally
    delayed discovery and produced financial documents at the “eleventh-hour [in an
    attempt] to cure his violation of a discovery order”).
    B. Assessment of Fees and Costs
    Federal Rule of Civil Procedure 37(b)(2)(C) requires the court to “order the
    disobedient party . . . to pay the reasonable expenses, including attorney’s fees,
    caused by the failure, unless the failure was substantially justified or other
    circumstances make an award of expenses unjust.” In addition, Rule 16(f)(2),
    governing Pretrial Conferences, Scheduling and Management, imposes similar
    obligations on the court regarding the payment of “reasonable expenses—including
    attorney’s fees—incurred because of any noncompliance with this rule[.]” “We
    review an award of sanctions pursuant to Rule 37(b) under the abuse of discretion
    standard.” Comiskey v. JFTJ Corp., 
    989 F.2d 1007
    , 1012 (8th Cir. 1993). We
    similarly review sanctions assessed under Rule 16(f) for an abuse of discretion.
    Gundacker v. Unisys Corp., 
    151 F.3d 842
    , 849 (8th Cir. 1998).
    Schubert argues the district court failed to conduct a de novo review of the
    magistrate judge’s award of costs and fees to Pfizer. Alternatively, Schubert argues
    since the district court failed to discuss at all the issue of costs and fees at the
    February 22, 2011, hearing, or in its February 28, 2011, order, it therefore must have
    rejected it.
    First, it is at best questionable whether Shubert properly objected to the
    magistrate judge’s recommendation to award Pfizer costs and fees. Although Shubert
    -9-
    requested an opportunity to be heard on the issue of costs and fees in his Reply to the
    Defendant’s Response to Plaintiff’s Objections on December 3, 2010, he never
    specifically objected to the December 17, 2010, order valuing the costs and fees at
    $53,255.55, nor did he raise the issue in front of the district court during the February
    22, 2011, hearing. Under these facts, we find it difficult to conclude the district court
    was required to conduct a de novo review on the issue of costs and fees. See 28
    U.S.C. § 636 (stating “A judge of the court shall make a de novo determination of
    those portions of the report or specified proposed findings or recommendations to
    which objection is made.”) (emphasis added); but see Belk v. Purkett, 
    15 F.3d 803
    ,
    815 (8th Cir. 1994) (emphasizing the importance of de novo review by the district
    court).
    Yet, even if we were to conclude Schubert’s request to be heard on the issue
    of fees and costs was sufficient to require the district court to conduct a de novo
    review, we cannot conclude the court failed to consider Schubert’s objection simply
    because the district court did not specifically refer to the magistrate judge’s
    determination of the appropriate monetary sanction. See United States v. Hamell, 
    931 F.2d 466
    , 468 (8th Cir. 1991) (“[I]n the absence of any evidence to the contrary, we
    presume that the [de novo] review was done properly and affirm the district court’s
    approval of the magistrate’s recommendation.”).
    Moreover, in this case there is evidence the district court did in fact consider
    the issue of costs and fees. The district court specifically stated it had carefully
    reviewed “the parties’ original submissions on both motions to dismiss, the parties’
    additional submission made after issuance of the Report, the transcript of the oral
    argument hearing on Defendants’ renewed motion to dismiss . . . and the parties’ oral
    arguments at the February 22, 2011 hearing.” Order Granting Mot. to Dismiss at 6,
    Feb. 28, 2011 (emphasis added). After explaining what it had reviewed, the district
    court stated it “adopt[ed] the Report in whole.” 
    Id. Accordingly, we
    reject
    Schubert’s argument the district court improperly failed to conduct a de novo review.
    -10-
    We also reject Schubert’s contention that by failing to specifically mention
    costs and fees either at the hearing or in its order the district court implicitly rejected
    the magistrate judge’s recommendation on that issue. Such a conclusion conflicts
    with the district court’s order stating it “adopts Judge Bremer’ [sic] Report and
    Recommendation (Clerks’ No. 92) in its Entirety.” Order Granting Mot. to Dismiss
    at 9, Feb. 28, 2011. (emphasis added). See, e.g., United States v. Alston, 
    626 F.3d 397
    , 400 (8th Cir. 2010) (noting that when “the district court adopt[s] the magistrate
    judge’s report and recommendation in its entirety, we hereafter refer to the findings
    and conclusions of the report and recommendation as those of the district court.”).
    Having concluded Schubert was afforded the proper review by the district
    court, and that the district court adopted the magistrate judge’s recommendation to
    award costs and fees to Pfizer, we must next ask if the court abused its discretion in
    awarding Pfizer the sum of $53,255.55 in costs and fees “for the period May 20
    through September 30, 2010, relating to the additional extraordinary discovery
    expense caused by Plaintiff’s noncompliance with discovery orders and Federal Rules
    of Civil Procedure.” Order on Fees and Costs, 2, December 17, 2010. We conclude
    it did not.
    “We are especially reluctant to substitute our judgment for that of the district
    court in the matter of appropriate attorney’s fees, because the district court is in the
    best position to determine whether hours were reasonably expended and whether an
    attorney’s hourly rates are reasonable[.]” 
    Arnold, 627 F.3d at 720
    (internal quotation
    marks and citation omitted). In this case, the court properly considered only the
    amount of fees and costs associated with Schubert’s failure to comply with court
    orders and Rule 16, and found Pfizer’s account of hours spent and hourly rates
    reasonable. In fact, the court decreased the amount Pfizer originally requested by
    over $11,000 to specifically limit the award to extra work performed by Pfizer due
    to Schubert’s misconduct during the appropriate time frame. Order on Fees and Costs
    at 4-5, Dec. 17, 2010. The sum awarded Pfizer, while significant, was within the
    -11-
    court’s discretion and is supported by the record. See 
    Comiskey, 989 F.2d at 1012
    (noting Rule 37 “authorizes an award encompassing all expenses, whenever incurred,
    that would not have been sustained had the opponent conducted itself properly[,]” and
    upholding an award of $6,407.50 in costs and fees) (internal quotation marks and
    citation omitted); First Am. State Bank v. Cont’l Ins. Co., 
    897 F.2d 319
    , 329 (8th Cir.
    1990) (upholding a monetary sanction of $2,191.64 under Rule 37(b) because counsel
    “unjustified[ly] and willfully delayed non-compliance with certain pretrial discovery
    orders” and because the record was “replete with egregious discovery abuse.”)
    III
    Accordingly, we affirm the district court’s dismissal with prejudice and the
    court’s assessment of costs and fees against Schubert in the amount of $53,255.55.
    ______________________________
    -12-